ClinicalTrials.govpublic full text
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
metastatic pancreatic ductal adenocarcinoma, quemliclustat, cd73 inhibitor, treatment naive, pancreatic cancer, prism-1, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 877329
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.